Cx Institutional’s Bristol-Myers Squibb Co Position
Does Cx Institutional own Bristol-Myers Squibb Co (BMY)? Yes — 263.6K shares worth $15M (+0.44% of its 13F portfolio) as of Q2 2026, up from 251.3K shares the prior filed quarter.
Position Value
$15M
Q2 2026
Shares
263.6K
% of Portfolio
+0.44%
Quarters Held
31
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 263.6K | $15M | +0.44% |
| Q1 2026 | 251.3K | $15M | +0.46% |
| Q4 2025 | 188.7K | $10M | +0.30% |
| Q3 2025 | 165.7K | $7M | +0.23% |
| Q2 2025 | 151.8K | $7M | +0.25% |
| Q1 2025 | 126.8K | $8M | +0.29% |
| Q4 2024 | 135.3K | $8M | +0.30% |
| Q3 2024 | 132.0K | $7M | +0.30% |
| Q2 2024 | 72.9K | $3M | +0.14% |
| Q1 2024 | 63.0K | $3M | +0.16% |
| Q4 2023 | 88.6K | $5M | +0.24% |
| Q3 2023 | 59.8K | $3M | +0.19% |
| Q2 2023 | 102.1K | $7M | +0.34% |
| Q1 2023 | 98.5K | $7M | +0.36% |
| Q4 2022 | 16.2K | $1M | +0.07% |
| Q3 2022 | 14.0K | $996,000 | +0.07% |
| Q2 2022 | 21.9K | $2M | +0.13% |
| Q1 2022 | 46.1K | $3M | +0.27% |
| Q4 2021 | 5.0K | $314,000 | +0.02% |
| Q3 2021 | 7.2K | $427,000 | +0.03% |
| Q2 2021 | 7.9K | $527,000 | +0.04% |
| Q1 2021 | 6.5K | $411,000 | +0.04% |
| Q4 2020 | 6.0K | $374,000 | +0.04% |
| Q3 2020 | 5.0K | $301,000 | +0.03% |
| Q2 2020 | 4.4K | $237,000 | +0.03% |
| Q1 2020 | 4.1K | $228,000 | +0.04% |
| Q4 2019 | 4.2K | $273,000 | +0.05% |
| Q3 2019 | 3.9K | $196,000 | +0.03% |
| Q2 2019 | 3.9K | $178,000 | +0.03% |
| Q1 2019 | 4.6K | $221,000 | +0.04% |
| Q4 2018 | 4.4K | $229,000 | +0.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cx Institutional’s full portfolio or all institutional holders of BMY.